Myriad Genetics, Inc. (LON:0K3W)
14.72
+0.50 (3.54%)
At close: Feb 19, 2025
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2023. The number of employees increased by 100 or 3.85% compared to the previous year.
Employees
2,700
Change (1Y)
100
Growth (1Y)
3.85%
Revenue / Employee
227.59K GBP
Profits / Employee
-32.05K GBP
Market Cap
1.02B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Myriad Genetics News
- 4 days ago - Myriad Genetics Included in Forbes America's Best Employers 2025 List - GlobeNewsWire
- 10 days ago - Myriad Genetics Inc (MYGN) Stock Price Up 8.56% on Feb 13 - GuruFocus
- 13 days ago - Wellington Management Group LLP Reduces Stake in Myriad Genetics Inc - GuruFocus
- 17 days ago - Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test - GlobeNewsWire
- 17 days ago - Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay - GlobeNewsWire
- 18 days ago - Myriad Genetics Inc (MYGN) Partners with Lumea Inc. to Enhance Molecular Diagnostic Testing - GuruFocus
- 18 days ago - Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration - GlobeNewsWire
- 25 days ago - Myriad Genetics Inc (MYGN) Unveils Groundbreaking Prenatal Screening Research - GuruFocus